Kelly Echevarria
-
- Antibiotic Use and Resistance 13
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 6
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 9
- Clostridium difficile and Clostridium perfringens research 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Patient Satisfaction in Healthcare 5
-
- Urinary Tract Infections Management 5
- Co-authors
- James S. LewisThomas C. HardinJean A. SmithJason E. BowlingDarrel W. HughesPamela R. MaxwellGary A. RoselleAnthony P. Morreale
- Journals
- SHILAP Revista de lepidopterología (6 papers)Clinical Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Kelly Echevarria
32 papers receiving 620 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 187
- Clinical Biochemistry 147
- Infectious Diseases 337
- Molecular Medicine 90
- Critical Care and Intensive Care Medicine 41
Countries citing papers authored by Kelly Echevarria
This map shows the geographic impact of Kelly Echevarria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Echevarria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Echevarria more than expected).
Fields of papers citing papers by Kelly Echevarria
This network shows the impact of papers produced by Kelly Echevarria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Echevarria. The network helps show where Kelly Echevarria may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelly Echevarria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 11 | |
| 14 | 2017 | 69 | |
| 15 | 2017 | 18 | |
| 16 | 2014 | 93 | |
| 17 | Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia | 2012 | 1 |
| 18 | 2012 | 15 | |
| 19 | 2011 | 62 | |
| 20 | 2010 | 37 |
About Kelly Echevarria
Kelly Echevarria is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Clinical Biochemistry, having authored 33 papers that have together received 638 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Bacterial Identification and Susceptibility Testing (6 papers), Patient Satisfaction in Healthcare (5 papers), Urinary Tract Infections Management (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (187 citations), Clinical Biochemistry (147 citations) and Infectious Diseases (337 citations). Kelly Echevarria has collaborated with scholars based in United States and Australia. Frequent co-authors include James S. Lewis, Thomas C. Hardin, Jean A. Smith, Jason E. Bowling, Darrel W. Hughes, Pamela R. Maxwell, Gary A. Roselle, Anthony P. Morreale, Melinda M. Neuhauser and Makoto Jones. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.